IPSC
Price
$1.84
Change
+$1.24 (+206.67%)
Updated
Feb 3 closing price
Capitalization
160.83M
36 days until earnings call
Intraday BUY SELL Signals
NTLA
Price
$13.05
Change
-$12.41 (-48.74%)
Updated
Feb 3 closing price
Capitalization
1.51B
15 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IPSC vs NTLA

Header iconIPSC vs NTLA Comparison
Open Charts IPSC vs NTLABanner chart's image
Century Therapeutics
Price$1.84
Change+$1.24 (+206.67%)
Volume$1.74M
Capitalization160.83M
Intellia Therapeutics
Price$13.05
Change-$12.41 (-48.74%)
Volume$3.62M
Capitalization1.51B
IPSC vs NTLA Comparison Chart in %
View a ticker or compare two or three
VS
IPSC vs. NTLA commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPSC is a Hold and NTLA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (IPSC: $1.84 vs. NTLA: $13.05)
Brand notoriety: IPSC and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPSC: 82% vs. NTLA: 72%
Market capitalization -- IPSC: $160.83M vs. NTLA: $1.51B
IPSC [@Biotechnology] is valued at $160.83M. NTLA’s [@Biotechnology] market capitalization is $1.51B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSC’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • IPSC’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, NTLA is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPSC’s TA Score shows that 3 TA indicator(s) are bullish while NTLA’s TA Score has 6 bullish TA indicator(s).

  • IPSC’s TA Score: 3 bullish, 5 bearish.
  • NTLA’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than IPSC.

Price Growth

IPSC (@Biotechnology) experienced а -30.57% price change this week, while NTLA (@Biotechnology) price change was -12.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.22%. For the same industry, the average monthly price growth was +3.03%, and the average quarterly price growth was +35.17%.

Reported Earning Dates

IPSC is expected to report earnings on Mar 12, 2026.

NTLA is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.51B) has a higher market cap than IPSC($161M). IPSC YTD gains are higher at: 84.962 vs. NTLA (45.161). IPSC has higher annual earnings (EBITDA): -909K vs. NTLA (-466.25M). NTLA has more cash in the bank: 511M vs. IPSC (133M). IPSC has less debt than NTLA: IPSC (45M) vs NTLA (98M). IPSC has higher revenues than NTLA: IPSC (113M) vs NTLA (57.5M).
IPSCNTLAIPSC / NTLA
Capitalization161M1.51B11%
EBITDA-909K-466.25M0%
Gain YTD84.96245.161188%
P/E RatioN/AN/A-
Revenue113M57.5M197%
Total Cash133M511M26%
Total Debt45M98M46%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IPSCNTLA
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 14 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
IPSC
Daily Signal:
Gain/Loss:
NTLA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SEQAX17.870.13
+0.73%
NAA World Equity Income A
PSBPX32.47-0.02
-0.06%
Principal SmallCap R5
HGHYX48.52-0.37
-0.76%
Hartford Healthcare Y
MUXYX28.36-0.24
-0.84%
Victory S&P 500 Index Y
RTLCX87.67-0.87
-0.98%
Russell Inv Tax-Managed US Large Cap C

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
N/A
CRSP - IPSC
54%
Loosely correlated
+1.34%
FATE - IPSC
50%
Loosely correlated
-5.69%
CABA - IPSC
49%
Loosely correlated
+3.60%
NTLA - IPSC
48%
Loosely correlated
-0.08%
KYTX - IPSC
47%
Loosely correlated
N/A
More